Serial Number 79419569
661

Registration Progress

Application Filed
Jan 23, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

Basic Information

Serial Number
79419569
Filing Date
January 23, 2025
Drawing Code
2

Status Summary

Current Status
Active
Status Code
661
Status Date
Dec 4, 2025
Application
Pending
Classes
005

Rights Holder

TAIHO PHARMACEUTICAL CO., LTD.

03
Address
1-27 Kandanishiki-cho,
Chiyoda-ku Tokyo 101-8444
JP

Ownership History

TAIHO PHARMACEUTICAL CO., LTD.

Original Applicant
03
JP

Legal Representation

Attorney
Norm J. Rich

Application History

13 events
Date Code Type Description Documents
Dec 4, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 4, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 4, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 30, 2025 RFNT P REFUSAL PROCESSED BY IB Loading...
Nov 10, 2025 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Nov 10, 2025 RFRR P REFUSAL PROCESSED BY MPU Loading...
Sep 24, 2025 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Sep 23, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 2, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 28, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 28, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 25, 2025 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Mar 20, 2025 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for treating hematological disorders; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines being anti-emetic preparations; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations; chemical reagents for medical purposes in the field of oncology.

Additional Information

Design Mark
The mark consists of one yellow triangle connected to a pink triangle, connected to an orange triangle that is connected to a blue and dark blue diamond at bottom. The color white represents background, outlining, shading, and/or transparent area and is/are not part of the mark.
Color Claim
The color(s) yellow, pink, orange, dark blue and blue is/are claimed as a feature of the mark.

Classification

International Classes
005